Clinical Trial Update: Efficacy and Safety of Mydriatic Microdrops Compared With Standard Drops for Retinopathy of Prematurity (ROP) Screening: a Pilot Randomized Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 pilot randomized trial evaluating the efficacy and safety of mydriatic microdrops versus standard drops for retinopathy of prematurity screening.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Mydriatic Microdrops
• Standard drops

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Retinopathy of Prematurity | Phase 4 | Status: COMPLETED